The Senior Director, Qualified Person (QP) is the senior leadership position accountable for the strategic
direction, governance and operational effectiveness of the QP function. The role supports the clinical and
commercial product portfolio across assigned territories. The role builds and leads the QP organisation,
establishes the QP operating model and decision framework, and ensures medicinal products are
certified and released in accordance with applicable Marketing Authorisations, Manufacturing and
Importation Authorisations, Good Manufacturing Practice (GMP), Annex 16 and clinical trial
The Senior Director provides independent, risk-based QP leadership across the product lifecycle; aligns
QP strategy with portfolio, launch, geographic expansion and patient-supply priorities; and serves as a
senior interface with regulatory authorities, Quality, CMC, Manufacturing, Supply Chain, Regulatory,
Clinical, Commercial, Patient Safety and external partners. As a member of the Distribution & Market
Quality leadership team, the role is accountable for organisational capability, talent, inspection readiness,
continuous improvement and sustained compliance across QP activities.
This position reports to: Executive Director, Distribution & Market Quality.
In-depth knowledge of UK and EU GMP requirements, Annex 16 batch-certification principles,
Marketing Authorisation and clinical-trial requirements, MIA licensing and current regulatory
expectations.
decisions in complex clinical and commercial supply environments.
models, and translate strategy into measurable objectives, resources and execution plans.
recommendations, constructively challenge, build consensus and resolve complex cross functional
issues.
principles, including ICH Q10, applied across the Pharmaceutical Quality System and product
lifecycle.
chains; experience with complex modalities, including cell and gene therapy, is desirable.
challenges, evaluate competing quality and supply considerations, and escalate material risks
appropriately.
management, external-service strategy and change leadership.
At Vertex, we embrace continuous learning and encourage employees to stay informed on advances in AI, technology, automation, and industry trends. We seek talent who bring an external perspective, demonstrate curiosity and sound judgment, and thoughtfully adopt new capabilities that improve decision-making, drive innovation, increase efficiency, and help deliver better outcomes for patients.
Remote-Eligible
In this Remote-Eligible role, you can choose to be designated as:
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
#LI-Remote
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at ApplicationAssistance@vrtx.com

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.
Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide.
Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards.
Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/